Title : Antidepressant activity of fingolimod in mice.

Pub. Date : 2015 Jun

PMID : 26171219






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Recent findings indicate that fingolimod, the first oral drug approved for the treatment of multiple sclerosis (MS), acts as a direct inhibitor of histone deacetylases (HDACs) and enhances the production of brain-derived neurotrophic factor (BDNF) in the CNS. Fingolimod Hydrochloride brain derived neurotrophic factor Mus musculus
2 Recent findings indicate that fingolimod, the first oral drug approved for the treatment of multiple sclerosis (MS), acts as a direct inhibitor of histone deacetylases (HDACs) and enhances the production of brain-derived neurotrophic factor (BDNF) in the CNS. Fingolimod Hydrochloride brain derived neurotrophic factor Mus musculus